tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Pelthos Therapeutics reports Q2 EPS ($5.38) vs ($3.07) last year
PremiumThe FlyPelthos Therapeutics reports Q2 EPS ($5.38) vs ($3.07) last year
2M ago
Pelthos Therapeutics target adjusted at Alliance after merger, reverse split
Premium
The Fly
Pelthos Therapeutics target adjusted at Alliance after merger, reverse split
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100